Concepedia

Pernille Lundqvist

PL

Statistics

Publications

2

Citations

414

H-Index

2

Active since

2013

Affiliations

Amgen (United States)(Current)

Pernille Lundqvist is an author at Amgen (United States) specializing in medicine, pharmacology, and atherosclerosis.

Top concepts

MedicinePharmacologyAtherosclerosisPharmacotherapyGastroenterologyNeuropharmacologyCardiovascular DiseaseChronic Inflammatory DiseasesGastrointestinal Pharmacology

Publications per year

2013–2014

2

Publications

2

Anti-PCSK9 Monotherapy for Hypercholesterolemia

Michael J. Koren, Pernille Lundqvist, Michael A. Bolognese et al. · Journal of the American College of Cardiology · 2014 · 399 citations

Lipid Disorder, Anti-pcsk9 Monotherapy, Cardiovascular Disease +6

520 Efficacy of Ibodutant, a Selective Antagonist of Neurokinin 2 Receptors, in Irritable Bowel Syndrome With Diarrhoea (IBS-D): The Results of a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Phase II Study (the IRIS-2)

Jan Tack, Yavor S. Dochev, Anna Bochenek et al. · Gastroenterology · 2013 · 15 citations

Chronic Inflammatory Diseases, Functional Gastrointestinal Disorder, Gastrointestinal Pharmacology +9

1–2 of 2